Literature DB >> 12027056

Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study.

S Kisely1, M Linden, C Bellantuono, G Simon, J Jones.   

Abstract

BACKGROUND: There has been growing interest in factors that might influence the prescription of psychotropic drugs in general practice.
METHOD: This was a multi-centre study using a two-phase stratified sampling strategy in primary care facilities from 14 different countries to determine factors associated with the prescription of psychotropic drugs.
RESULTS: A total of 1763 consecutive GP attenders aged between 16 and 65 years of age were recruited. Although antidepressants were used more for depressive disorders and anxiolytics for patients with anxiety, the differential diagnosis was otherwise not an important factor in prescribing behaviour. Antidepressants and anxiolytics were prescribed twice as frequently in client centred clinics following a 'personal physician model' as opposed to non-client centred settings, where care was less personalized. The reverse was true of hypnotics (adjusted odds ratio of 0.5). General practitioners with a positive view of their undergraduate psychiatric training and who had had further postgraduate experience in the speciality were significantly less likely to prescribe medication, and if they did they were more likely to use antidepressants. Older patients were significantly more likely to be prescribed psychotropic medication. Several other patient factors emerged when individual classes of medication were considered; these included the loss of a spouse and the absence of physical ill health in the case of antidepressants, and female sex, fewer years of schooling and unemployment in the case of anxiolytics.
CONCLUSIONS: Social, health care and GP factors are at least as important as clinical features in the prescription and choice of psychotropic medication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12027056     DOI: 10.1017/s0033291799002743

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  6 in total

1.  Deciding who gets treatment for depression and anxiety: a study of consecutive GP attenders.

Authors:  Julia Hyde; Jonathan Evans; Debbie Sharp; Tim Croudace; Glynn Harrison; Glyn Lewis; Ricardo Araya
Journal:  Br J Gen Pract       Date:  2005-11       Impact factor: 5.386

2.  Primary care physicians' evaluation and treatment of depression: Results of an experimental study using video vignettes.

Authors:  Steven A Epstein; Lisa M Hooper; Kevin P Weinfurt; Venita DePuy; Lisa A Cooper; William G Harless; Cynthia M Tracy
Journal:  Med Care Res Rev       Date:  2008-10-01       Impact factor: 3.929

3.  General practitioners' choices and their determinants when starting treatment for major depression: a cross sectional, randomized case-vignette survey.

Authors:  Hélène Dumesnil; Sébastien Cortaredona; Hélène Verdoux; Rémy Sebbah; Alain Paraponaris; Pierre Verger
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

4.  Prevalence of and factors related to the use of antidepressants and benzodiazepines: results from the Singapore Mental Health Study.

Authors:  Mythily Subramaniam; Vincent Y F He; Janhavi A Vaingankar; Edimansyah Abdin; Siow Ann Chong
Journal:  BMC Psychiatry       Date:  2013-09-23       Impact factor: 3.630

5.  Patient factors associated with guideline-concordant treatment of anxiety and depression in primary care.

Authors:  Marijn A Prins; Peter F M Verhaak; Mirrian Smolders; Miranda G H Laurant; Klaas van der Meer; Peter Spreeuwenberg; Harm W J van Marwijk; Brenda W J H Penninx; Jozien M Bensing
Journal:  J Gen Intern Med       Date:  2010-01-05       Impact factor: 5.128

6.  Educating and informing patients receiving psychopharmacological medications: are family physicians in Pakistan up to the task?

Authors:  Hammad Ashraf Ganatra; Hadi Bhurgri; Roomasa Channa; Fauzia Ahmad Bawany; Syed Nabeel Zafar; Rafia Ishfaq Chaudhry; Syeda Hina Batool; Abdul Basit; Mehmood Asghar; Sarah Saleem; Haider Naqvi
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.